Mulligan Seamus Insider Trading Activity

Average Profitability
20.05%
Insider Buys Quantity
3
Insider Buys Sum
$12.78M
Insider Sells Quantity
18
Insider Sells Sum
$536.04M

Insider Activity of Mulligan Seamus

Biography of Mulligan Seamus

No biography is available at this moment.

2025-05-12PurchaseJazz Pharmaceuticals plc
JAZZ
director
1,621
0.0026%
$103.00$166,962+33.74%
2025-05-09PurchaseJazz Pharmaceuticals plc
JAZZ
director
100,000
0.1631%
$98.26$9.83M+41.59%
2020-05-27PurchaseJazz Pharmaceuticals plc
JAZZ
director
35,000
0.062%
$111.26$3.89M+31.91%
2020-05-26PurchaseJazz Pharmaceuticals plc
JAZZ
director
15,000
0.0274%
$110.65$1.66M+36.51%
2018-11-15PurchaseJazz Pharmaceuticals plc
JAZZ
director
50,000
0.0839%
$144.56$7.23M-8.28%
2016-08-25SaleJazz Pharmaceuticals plc
JAZZ
director
27,968
0.0466%
$128.32$3.59M+5.91%
2016-05-24SaleJazz Pharmaceuticals plc
JAZZ
director
27,968
0.0458%
$150.29$4.2M-11.73%
2016-02-23SaleJazz Pharmaceuticals plc
JAZZ
director
27,968
0.046%
$122.71$3.43M+3.81%
2015-11-23SaleJazz Pharmaceuticals plc
JAZZ
director
10,243
0.0167%
$147.90$1.51M-9.47%
2015-11-20SaleJazz Pharmaceuticals plc
JAZZ
director
17,725
0.0291%
$144.68$2.56M-6.39%
2015-03-25SaleJazz Pharmaceuticals plc
JAZZ
director
100,000
0.1659%
$174.63$17.46M-13.44%
2015-03-18SaleJazz Pharmaceuticals plc
JAZZ
director
100,000
0.1633%
$185.00$18.5M-14.14%
2014-12-26SaleJazz Pharmaceuticals plc
JAZZ
director
6,616
0.0109%
$166.19$1.1M+3.31%
2014-12-24SaleJazz Pharmaceuticals plc
JAZZ
director
26,834
0.0444%
$165.63$4.44M+4.01%
2014-12-23SaleJazz Pharmaceuticals plc
JAZZ
director
66,550
0.1089%
$162.22$10.8M+5.18%
2014-09-25SaleJazz Pharmaceuticals plc
JAZZ
director
29,412
0.0494%
$161.84$4.76M+8.69%
2014-09-24SaleJazz Pharmaceuticals plc
JAZZ
director
70,588
0.1161%
$163.70$11.56M+5.33%
2014-09-11SaleJazz Pharmaceuticals plc
JAZZ
director
100,000
0.1686%
$175.00$17.5M+0.99%
2014-06-25SaleJazz Pharmaceuticals plc
JAZZ
director
94
0.0002%
$148.64$13,972+12.9%
2014-06-24SaleJazz Pharmaceuticals plc
JAZZ
director
99,906
0.1696%
$149.70$14.96M+14.61%
Total: 23
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.